Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.

Sprecher DL, Abrams J, Allen JW, Keane WF, Chrysant SG, Ginsberg H, Fischer JJ, Johnson BF, Theroux P, Jokubaitis L.

Ann Intern Med. 1994 Apr 1;120(7):537-43.

PMID:
8093139
2.

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.

PMID:
18343245
3.
4.

Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination.

Leitersdorf E, Muratti EN, Eliav O, Meiner V, Eisenberg S, Dann EJ, Sehayek E, Peters TK, Stein Y.

Am J Med. 1994 May;96(5):401-7.

PMID:
8192170
5.

Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.

Bard JM, Ose L, Hagen E, Duriez P, Pfister P, Fruchart JC, Dallongeville J.

Am J Cardiol. 1995 Jul 13;76(2):65A-70A.

PMID:
7604802
6.
7.

Fluvastatin in combination with other lipid-lowering agents.

Jokubaitis LA.

Br J Clin Pract Suppl. 1994 Dec;(77):28-32. Update in: Br J Clin Pract Suppl. 1996 Jan;77A:28-32.

PMID:
19496270
8.

Fluvastatin in combination with other lipid-lowering agents.

Jokubaitis LA.

Br J Clin Pract Suppl. 1996 Jan;77A:28-32. Review.

PMID:
8729588
9.

Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.

Hagen E, Istad H, Ose L, Bodd E, Eriksen HM, Selvig V, Bard JM, Fruchart JC, Borge M, Wolf MC, et al.

Eur J Clin Pharmacol. 1994;46(5):445-9.

PMID:
7957541
10.
11.

Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia.

Betteridge DJ, Durrington PN, Fairhurst GJ, Jackson G, McEwan MS, McInnes GT, Miller JP, Mir MA, Reckless JP, Rees-Jones DI, et al.

Am J Med. 1994 Jun 6;96(6A):45S-54S.

PMID:
8017467
12.

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.

Ballantyne CM, Pazzucconi F, Pintó X, Reckless JP, Stein E, McKenney J, Bortolini M, Chiang YT.

Clin Ther. 2001 Feb;23(2):177-92.

PMID:
11293552
13.

Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.

Leitersdorf E, Muratti EN, Eliav O, Peters TK.

Am J Cardiol. 1995 Jul 13;76(2):84A-88A.

PMID:
7604807
14.

Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial.

Olsson AG, Pauciullo P, Soska V, Luley C, Pieters RE, Broda G, Palacios B; Fluvastatin Study Group..

Clin Ther. 2001 Jan;23(1):45-61.

PMID:
11219479
15.
16.

Fluvastatin with and without niacin for hypercholesterolemia.

Jacobson TA, Chin MM, Fromell GJ, Jokubaitis LA, Amorosa LF.

Am J Cardiol. 1994 Jul 15;74(2):149-54.

PMID:
8023779
17.

Fluvastatin in familial hypercholesterolemia: a cohort analysis of the response to combination treatment.

Muratti EN, Peters TK, Leitersdorf E.

Am J Cardiol. 1994 May 26;73(14):30D-38D.

PMID:
8198022
Items per page

Supplemental Content

Support Center